Skip to content

Sofalcone Synthesis Essay

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.[PubMed]

2. Mutoh M, Takahashi M, Wakabayashi K. Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention. Curr Pharm Des. 2006;12:2375–2382.[PubMed]

3. Komiya M, Fujii G, Takahashi M, Iigo M, Mutoh M. Prevention and intervention trials for colorectal cancer. Jpn J Clin Oncol. 2013;43:685–694.[PubMed]

4. Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376:1741–1750.[PubMed]

5. Ishikawa H, Mutoh M, Suzuki S, Tokudome S, Saida Y, Abe T, Okamura S, Tajika M, Joh T, Tanaka S, Kudo SE, Matsuda T, Iimuro M, et al. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. Gut. 2014;63:1755–1759.[PubMed]

6. Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ, Chaussade S, Baron JA. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst. 2009;101:256–266.[PubMed]

7. Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, Oikawa S, Sugawara M, Ando K, Murata M, Yokoyama K, Ishizuka N. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial. JAMA. 2014;312:2510–2520.[PubMed]

8. Wang LS, Kuo CT, Huang YW, Stoner GD, Lechner JF. Gene-diet interactions on colorectal cancer risk. Curr Nutr Rep. 2012;1:132–141.[PMC free article][PubMed]

9. Watson SA, Smith AM. Hypergastrinemia promotes adenoma progression in the APC (Min-/+) mouse model of familial adenomatous polyposis. Cancer Res. 2001;61:625–631.[PubMed]

10. Sugie S, Okamoto K, Watanabe T, Tanaka T, Mori H. Suppressive effect of irsogladine maleate on N-methyl-N’-nitro-N-nitrosoguanidine (MNNG)-initiated and glyoxal-promoted gastric carcinogenesis in rats. Toxicol. 2001;166:53–61.[PubMed]

11. Sugie S, Okamoto K, Ueda F, Watanabe T, Tanaka T, Mori H. Suppressive effect of irsogladine maleate on diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis in male F344 rats. Jpn J Cancer Res. 1998;89:371–376.[PubMed]

12. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066–1071.[PubMed]

13. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 1994;10:405–455.[PubMed]

14. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991;1072:129–157.[PubMed]

15. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995;270:16483–16486.[PubMed]

16. Schindler C, Darnell JE., Jr Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995;64:621–651.[PubMed]

17. DiDonato JA, Mercurio F, Karin M. NF-κB and the link between inflammation and cancer. Immunol Rev. 2012;246:379–400.[PubMed]

18. Henkel T, Machleidt T, Alkalay I, Krönke M, Ben-Neriah Y, Baeuerle PA. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature. 1993;365:182–185.[PubMed]

19. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol. 1990;10:2327–2334.[PMC free article][PubMed]

20. Zhang YH, Lin JX, Vilcek J. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol. 1990;10:3818–3823.[PMC free article][PubMed]

21. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med. 2009;47:469–484.[PubMed]

22. Kawai Y, Takeda S, Terao J. Lipidomic analysis for lipid peroxidation-derived aldehydes using gas chromatography-mass spectrometry. Chem Res Toxicol. 2007;20:99–107.[PubMed]

23. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;7:599–612.[PubMed]

24. Bartsch H, Nair J. Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies. Mutat Res. 2005;591:34–44.[PubMed]

25. Williams MV, Lee SH, Pollack M, Blair IA. Endogenous lipid hydroperoxide-mediated DNA-adduct formation in min mice. J Biol Chem. 2006;281:10127–10133.[PubMed]

26. Akakabe Y, Nyuugaku T. An efficient conversion of carboxylic acids to one-carbon degraded aldehydes via 2-hydroperoxy acids. Biosci Biotechnol Biochem. 2007;71:1370–1371.[PubMed]

27. Hamberg M, Sanz A, Castresana C. Alpha-oxidation of fatty acids in higher plants. Identification of a pathogen-inducible oxygenase (piox) as an alpha-dioxygenase and biosynthesis of 2-hydroperoxylinolenic acid. J Biol Chem. 1999;274:24503–24513.[PubMed]

28. Wentworth P, Jr, McDunn JE, Wentworth AD, Takeuchi C, Nieva J, Jones T, Bautista C, Ruedi JM, Gutierrez A, Janda KD, Babior BM, Eschenmoser A, Lerner RA. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science. 2002;298:2195–2199.[PubMed]

29. Niho N, Takahashi M, Kitamura T, Shoji Y, Itoh M, Noda T, Sugimura T, Wakabayashi K. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res. 2003;63:6090–6095.[PubMed]

30. Tomono S, Miyoshi N, Ohshima H. Comprehensive analysis of the lipophilic reactive carbonyls present in biological specimens by LC/ESI-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;988:149–156.[PubMed]

- Он обошел Сквозь строй. Посмотри. Бринкерхофф растерянно постоял минутку, затем подбежал к окну и встал рядом с Мидж.